MAKANA THERAPEUTICS
Makana Therapeutics is focused on developing swine with reduced xenoantigen expression, making human transplantation of cells, tissues and organs from these animals possible. Makana’s focus on simplified genetics, optimized pig cloning techniques, and careful patient selection is expected to streamline product development and result in safer more efficacious products. It was founded in 2009 and is based in Miami, Florida, United States.
MAKANA THERAPEUTICS
Social Links:
Industry:
Biotechnology Health Care Life Science
Founded:
2009-01-01
Address:
Miami, Florida, United States
Country:
United States
Status:
Active
Similar Organizations
2bPrecise
Precision medicine is rewriting the rules of health care. And 2bPrecise is rewriting the rules of precision medicine.
Penn Medicine Co-Investment Program
Penn Medicine Co-Investment Program makes investments in faculty-driven cell therapy, gene therapy, and connected health companies
More informations about "Makana Therapeutics"
About Makana Therapeutics - Makana Therapeutics Inc
At Makana Therapeutics, Mariana supports the laboratory efforts for developing assays and manages the storage and organization of samples. Juan Lasalle. Research Associate. Juan …See details»
Our Company - Makana Therapeutics
Makana Therapeutics (originally known as Xenobridge, LLC) was founded in 2009 by Joe Tector, MD, PhD, FACS. The son of a Cardiothoracic Transplant surgeon, Dr. Tector became …See details»
Makana Therapeutics - Crunchbase Company Profile
Makana Therapeutics is focused on developing swine with reduced xenoantigen expression, making human transplantation of cells, tissues and organs from these animals possible. Makana’s focus on simplified genetics, optimized pig cloning …See details»
Makana Therapeutics Company Profile 2025: Valuation, …
Makana Therapeutics General Information Description. Provider of xenotransplantation services intended to solve organ shortage. The company focuses on commercializing a pipeline of transplantable cells, tissues, and …See details»
Recombinetics Merges with Makana Therapeutics to …
Recombinetics Inc. and Makana Therapeutics have expertise and strong intellectual property positions in clinical organ transplantation, genetic engineering, reproductive technology, and xenotransplantation. ... “Makana …See details»
Makana Therapeutics - LinkedIn
Makana Therapeutics will be exclusively focused on solving the organ shortage crisis. We are focusing on and commercializing a pipeline of transplantable cells, tissues, and organs for …See details»
Makana™ Therapeutics Announces Relocation of Its …
Apr 7, 2022 About Makana Therapeutics. Founded in 2009, Makana Therapeutics is focused on developing swine with reduced xenoantigen expression, making human transplantation of cells, tissues and organs from ...See details»
AAKP Innovator Series: Makana Therapeutics
Apr 3, 2023 Founded in 2009, Makana Therapeutics is focused on developing pigs with reduced xenoantigen expression, making human transplantation of cells, tissues, and organs from these animals possible. Makana’s focus on simplified …See details»
Scientific Breakthrough Addresses Rejection in Pig-To-Human …
Sep 4, 2024 Makana Therapeutics announced on Sept. 4 that the company’s scientists have discovered that pigs contain a fourth gene that when inactivated will greatly reduce the risk of …See details»
Makana™ Announces Major Breakthrough to Address Rejection in …
MIAMI, September 04, 2024--Makanaâ„¢ Therapeutics, a global leader in the field of xenotransplantation, announced today that the company’s scientists have discovered that pigs …See details»
Makana News - Makana Therapeutics
Sep 4, 2024 About Makana Therapeutics Founded in 2009, Makana Therapeutics is focused on developing swine with reduced xenoantigen expression, making human transplantation of …See details»
Recombinetics Inc. Merges with Makana Therapeutics to
Oct 8, 2020 According to Mark Platt, President and CEO of Recombinetics Inc., “Makana Therapeutics is the ideal fit for our organization – this is a force multiplier. With our combined …See details»
Makana Therapeutics - Products, Competitors, Financials, …
Makana Therapeutics is a biotechnology company specializing in xenotransplantation for the healthcare sector. The company's main offerings include genetically modified pigs for human …See details»
Makana Therapeutics, Inc. Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Makana Therapeutics, Inc. of Eagan, MN. Get the latest business insights from Dun & Bradstreet.See details»
Xenotransplantation - Makana Therapeutics
Makana Therapeutics is uniquely positioned to achieve this goal. Why do Transplants Fail? The human immune system protects individuals from substances that may be harmful, such as …See details»
Makana Therapeutics - Contacts, Employees, Board Members
Organization. Makana Therapeutics . Connect to CRM . Save . Summary. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 3. Contacts 4. ... Makana …See details»
Recombinetics Inc. Merges with Makana Therapeutics to …
Oct 8, 2020 According to Mark Platt, President and CEO of Recombinetics Inc., "Makana Therapeutics is the ideal fit for our organization – this is a force multiplier. With our combined …See details»
Makana Therapeutics - Facebook
Makana Therapeutics. 16 likes. Makana Therapeutics is focused on developing swine with reduced xenoantigen expression, making human transplantation of cells, tissues and organs …See details»
Akebia Therapeutics Announces Multiple Positive Business Updates
6 hours ago Akebia Therapeutics®, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today announced multiple …See details»
Makana In The News - Makana Therapeutics
Oct 14, 2024 Makana Leading Miami’s Emerging Hub for Biotech Innovation. Nestled in the vibrant ecosystem of Miami, Makana epitomizes Florida’s burgeoning prominence in the …See details»